Table 3. Recognition of each cancer symptom according to the nine ethnic groups, with percentage of participants who recognised each symptom and odds ratios (99% confidence intervals) adjusted for age group, gender and deprivation (n=38 492).
Symptoms/ethnic groups | White British | White Irish | Indian | Pakistani | Bangladeshi | Black Caribbean | Black African | Chinese | Other |
---|---|---|---|---|---|---|---|---|---|
Unexplained lump or swelling | 96% | 94% | 87% | 83% | 77% | 88% | 83% | 89% | 88% |
1.00 | 0.74 (0.43–1.26) | 0.27a (0.20–0.36) | 0.23a (0.17–0.31) | 0.15a (0.11–0.21) | 0.32a (0.24–0.43) | 0.22a (0.17–0.28) | 0.33a (0.17–0.63) | 0.30a (0.25–0.35) | |
Unexplained persistent pain | 79% | 80% | 71% | 71% | 70% | 72% | 66% | 80% | 74% |
1.00 | 1.05 (0.77–1.43) | 0.65a (0.53–0.80) | 0.68a (0.54–0.86) | 0.67a (0.50–0.89) | 0.71a (0.58–0.88) | 0.54a (0.45–0.65) | 1.04 (0.63–1.69) | 0.74a (0.66–0.84) | |
Unexplained bleeding | 87% | 88% | 76% | 73% | 69% | 77% | 67% | 75% | 75% |
1.00 | 1.09 (0.75–1.59) | 0.55a (0.44–0.69) | 0.51a (0.40–0.65) | 0.44a (0.33–0.58) | 0.56a (0.45–0.70) | 0.36a (0.30–0.44) | 0.53a (0.33–0.84) | 0.53a (0.47–0.59) | |
Persistent cough or hoarseness | 70% | 69% | 59% | 57% | 53% | 56% | 51% | 58% | 61% |
1.00 | 0.98 (0.75–1.29) | 0.73a (0.60–0.88) | 0.70a (0.57–0.87) | 0.61a (0.47–0.79) | 0.63a (0.52–0.76) | 0.55a (0.46–0.66) | 0.70 (0.47–1.05) | 0.78a (0.70–0.87) | |
Bowel/bladder habits change | 89% | 89% | 74% | 70% | 61% | 74% | 65% | 71% | 76% |
1.00 | 1.08 (0.72–1.62) | 0.41a (0.33–0.51) | 0.37a (0.29–0.46) | 0.25a (0.19–0.33) | 0.41a (0.33–0.51) | 0.28a (0.23–0.33) | 0.36a (0.23–0.55) | 0.46a (0.41–0.53) | |
Difficulty in swallowing | 77% | 79% | 61% | 58% | 49% | 62% | 51% | 60% | 64% |
1.00 | 1.14 (0.85–1.55) | 0.54a (0.44–0.66) | 0.51a (0.41–0.63) | 0.36a (0.28–0.47) | 0.55a (0.45–0.66) | 0.37a (0.31–0.45) | 0.52a (0.35–0.77) | 0.62a (0.56–0.69) | |
Change in mole appearance | 94% | 89% | 75% | 67% | 59% | 77% | 66% | 74% | 79% |
1.00 | 0.53a (0.36–0.80) | 0.20a (0.16–0.25) | 0.15a (0.12–0.19) | 0.11a (0.08–0.14) | 0.24a (0.19–0.30) | 0.14a (0.11–0.17) | 0.18a (0.11–0.30) | 0.25a (0.22–0.29) | |
Sore that does not heal | 69% | 68% | 59% | 57% | 51% | 55% | 53% | 50% | 61% |
1.00 | 0.97 (0.75–1.27) | 0.75a (0.61–0.91) | 0.72a (0.58–0.89) | 0.58a (0.45–0.76) | 0.60a (0.50–0.72) | 0.60a (0.51–0.72) | 0.51a (0.34–0.76) | 0.79a (0.72–0.88) | |
Unexplained weight loss | 86% | 84% | 73% | 70% | 69% | 74% | 65% | 75% | 75% |
1.00 | 0.89 (0.64–1.26) | 0.53a (0.43–0.66) | 0.46a (0.37–0.59) | 0.46a (0.35–0.61) | 0.53a (0.43–0.66) | 0.37a (0.31–0.45) | 0.58a (0.37–0.92) | 0.57a (0.51–0.65) |
These estimates were derived from a model including one of the ethnic groups and each of the cancer symptoms, adjusted for age groups, gender and deprivation, measured using quintiles of the income domain of indices of multiple deprivation index.
Statistically significant at P<0.01 level (99% confidence intervals).